Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / DMTK - DocGo DermTech Kenvue and GigaCloud Class Action Update: Johnson Fistel Alerts Shareholders of Ongoing Legal Proceedings | Benzinga


DMTK - DocGo DermTech Kenvue and GigaCloud Class Action Update: Johnson Fistel Alerts Shareholders of Ongoing Legal Proceedings | Benzinga

  • SAN DIEGO, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP, a law firm specializing in shareholder rights, has announced the initiation of class action lawsuits on behalf of investors of the following companies. Investors are encouraged to review the deadlines listed and submit their information.

    DocGo, Inc: https://www.johnsonfistel.com/investigations/docgo-inc

    DermTech, Inc: https://www.johnsonfistel.com/investigations/dermtech-inc-nasdaq-dmtk

    Kenvue Inc: https://www.johnsonfistel.com/investigations/kenvue-inc

    GigaCloud Technology Inc: https://www.johnsonfistel.com/investigations/gigacloud-technology

    If you suffered a loss and are interested in learning more about being a lead plaintiff, please contact Jim Baker (jimb@johnsonfistel.com) by email or phone at 619-814-4471. If emailing, please include a phone number.

    DocGo, Inc. (NASDAQ:DCGO)

    Class Period: November 8, 2022 and September 17, 2023

    Lead Plaintiff Deadline: December 26, 2023

    Join the Class Action Here

    The lawsuit alleges DocGo made false or misleading statements and/or omitted material adverse information regarding the Company's business, operations, and prospects, including: (i) DocGo's executive hiring processes were inadequate to fully review and vet the professional and academic backgrounds of job candidates; (ii) the foregoing increased the likelihood of disruptive executive turnover; (iii) contrary to its representations to investors, DocGo had overstated the efficacy of its mobile health and medical transportation services; and (iv) all of the foregoing, once revealed, was likely to subject DocGo to significant reputational and/or regulatory scrutiny that would negatively impact the Company's financial position and/or prospects.

    DermTech, Inc. (NASDAQ:DMTK)

    Class Period: May ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: DermTech Inc
    Stock Symbol: DMTK
    Market: NYSE

    Menu

    DMTK DMTK Quote DMTK Short DMTK News DMTK Articles DMTK Message Board
    Get DMTK Alerts

    News, Short Squeeze, Breakout and More Instantly...